Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
The latest update is out from Tonix Pharma (TNXP).
Tonix Pharmaceuticals Holding Corp. has updated its investor presentation and its TNX-102 SL product information, which may include nonpublic details, and plans to make these updates available on its website. Moreover, the company recently held a critical Type B CMC and pre-NDA meeting with the FDA regarding its product Tonmya™ and is currently awaiting the official minutes from this meeting. These updates are significant for investors tracking the company’s progress and regulatory milestones.
Find detailed analytics on TNXP stock on TipRanks’ Stock Analysis page.